Paradeep Phosphates Board Approves FY26 Results, Recommends Dividend
Paradeep Phosphates Limited announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board recommended a dividend of ₹1.50 per equity share. Mrs. Rita Menon was re-appointed as an Independent Director for a three-year term starting June 27, 2026.
The approval of financial results and dividend recommendation are material events for investors. The re-appointment of a director is also significant for corporate governance.
The company reported its financial results and recommended a dividend, which are generally positive indicators for shareholders. The re-appointment of an experienced director also adds to stability.
Paradeep Phosphates Limited (PPL) announced the outcome of its Board Meeting held on May 11, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
Additionally, the Board recommended a dividend of ₹1.50 per equity share of ₹10 each for the financial year ended March 31, 2026. This dividend is subject to the approval of the shareholders at the upcoming Annual General Meeting (AGM).
The Board also approved the re-appointment of Mrs. Rita Menon as an Independent Director for a second term of three years, effective from June 27, 2026, subject to shareholder approval. Mrs. Menon, a former IAS officer, has a distinguished career in public service and currently serves on the board of another listed company. The company confirmed that she has not been debarred from holding a director's office by any regulatory authority.
The audited financial results for FY26, both standalone and consolidated, were issued with an unmodified opinion by the statutory auditors, M/s. BSR & Co. LLP. The Board meeting commenced at 3:00 PM IST and concluded at 5:30 PM IST on May 11, 2026.
What to do with a filing like this
Paradeep Phosphates Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Paradeep Phosphates Limited. Read the original for the full detail.